Free CPD-accredited courses by Dr Emilė Radytė cover how hormonal changes affect the brain and influence pain, mood, and cognition.

The page explains dysmenorrhea, affecting up to 80% of women, including symptoms, causes, and treatments for period pain.

The page explains endometriosis, affecting 1 in 10 women, including symptoms, causes, diagnosis, and treatments for chronic pelvic pain.

The page explains perimenopause, the hormonal transition before menopause, including symptoms, causes, and treatments, including brain-based approaches.

Executive dysfunction undermines the daily routines reliable contraception depends on, yet the research linking ADHD to higher unintended pregnancy risk is largely absent from clinical guidance. What the evidence shows, the drug interaction no one flags, and what better care looks like.

Evidence-based articles on women's health, hormones, and neuroscience — from the team at Samphire Neuroscience.

The Cycle Brain Guide explores the relationship between menstrual cycles and brain health, backed by evidence.

The HCP Data Pack provides clinical evidence and prescribing guidance for Samphire Neuroscience devices.

Own the US commercial launch and clinical partner network for a brain-based medical device company entering the women's health market.

The clinical face of Samphire in Europe — building KOL relationships, delivering scientific exchange, and supporting evidence generation across the EU and UK.

Samphire develops brain-based technologies to address the neuroscience of hormonal change, collaborating with global researchers.

Samphire investigates how hormonal changes influence pain, mood, and focus by studying brain responses and clinical research.

Find answers to common questions about Samphire Neuroscience products, shipping, returns, and more.

Browse FAQs, categories and step‑by‑step guides for Samphire products and the app.

Samphire develops brain-based technologies to address pain and mood symptoms caused by hormonal change, shifting focus from hormone treatment.

The page outlines how Samphire collects, uses, and safeguards personal data.

Returns, refunds and ownership conversion for the Samphire Headband and annual Care Memberships.

Terms and conditions for using Samphire Neuroscience's website, app, and products.

Samphire introduces a non-invasive headband using transcranial direct current stimulation (tDCS) to help women manage PMS or PMDD symptoms at home. The device delivers low-level electrical stimulation to brain regions linked to emotional regulation, offering an alternative to medication or hormones without requiring a prescription. The company prioritizes both clinical effectiveness and user experience in its design.

Oct 2026TIMENews article

Samphire Neuroscience, a neuroscience-focused startup, has evolved since its founding. The company operates at the intersection of technology and neuroscience, though specific details about its current projects or advancements are not provided in this retrospective piece.

Apr 2026Startups MagazineNews article

Lutea introduces a non-pharmaceutical wearable that uses brain stimulation to address hormonal mood fluctuations during menstrual cycles. The device targets emotional volatility like anxiety and mental fog without relying on medication or supplements. Early focus centers on easing period-related stress through targeted neural modulation.

Oct 2025CNETNews article

Nettle™ users report fewer sick days, reduced medication use, and fewer GP visits after six months. Over 80% say they regain nearly a month of life annually, while 90% adjust their painkiller or hormone use. More than half wish healthcare providers recommended Nettle™ first, highlighting its potential to improve menstrual health outcomes.

Sep 2025samphireneuro.comNews article